Patents by Inventor Brian Lavan

Brian Lavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
    Patent number: 7510851
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia. In particular, the invention provides methods of identifying modulators of AKR1C as well as methods of diagnosing diabetes by measuring the levels of AKR1C or 9?, 11?-PGF2? in a patient.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: March 31, 2009
    Assignee: Metabolex, Inc.
    Inventors: Steve Waters, Shonna Moodie, Brian Lavan, Thomas A. Gustafson
  • Methods of diagnosing & treating diabetes and insulin resistance
    Publication number: 20060292563
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes and insulin resistance. In particular, the invention provides methods of identifying modulators of the polynucleotides or polypeptides of the invention and using those modulators to treat diabetes, as well as methods of diagnosing diabetes by measuring the levels of the polynucleotides or polypeptides of the invention in a patient.
    Type: Application
    Filed: June 5, 2003
    Publication date: December 28, 2006
    Applicant: Metabolex, Inc.
    Inventors: Bernard Allan, Brian Lavan, Shonna Moodie, Chi-Wai Wong
  • Methods of diagnosing and treating diabetes and insulin resistance
    Publication number: 20060234292
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes and insulin resistance. In particular, the invention provides methods of identifying modulators of the polynucleotides or polypeptides of the invention and using those modulators to treat diabetes, as well as methods of diagnosing diabetes by measuring the levels of the polynucleotides or polypeptides of the invention in a patient.
    Type: Application
    Filed: June 5, 2003
    Publication date: October 19, 2006
    Inventors: Bernard Allan, Francine Gregoire, Brian Lavan, Shonna Moodie, Steve Waters, Chi-Wai Wong
  • Methods of diagnosing and treating diabetes and insulin resistance
    Publication number: 20060228706
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes and insulin resistance. In particular, the invention provides methods of identifying modulators of the polynucleotides or polypeptides of the invention and using those modulators to treat diabetes, as well as methods of diagnosing diabetes by measuring the levels of the polynucleotides or polypeptides of the invention in a patient.
    Type: Application
    Filed: June 4, 2003
    Publication date: October 12, 2006
    Applicant: Metabolex, Inc.
    Inventors: Allan Bernard, Brian Lavan, Shonna Moodie, Steve Waters, Chi-Wai Wong
  • Methods of diagnosing & treating diabetes and insulin resistance
    Publication number: 20060074018
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes and insulin resistance. In particular, the invention provides methods of identifying modulators of the polynucleotides or polypeptides of the invention and using those modulators to treat diabetes, as well as methods of diagnosing diabetes by measuring the levels of the polynucleotides or polypeptides of the invention in a patient.
    Type: Application
    Filed: June 4, 2003
    Publication date: April 6, 2006
    Applicant: Metabolex Inc
    Inventors: Allan Bernard, Francine Gregoire, Brian Lavan, Shonna Moodie
  • Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
    Publication number: 20030186871
    Abstract: The present invention provides compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia. In particular, the invention provides methods of identifying modulators of AKR1C as well as methods of diagnosing diabetes by measuring the levels of AKR1C or 9&agr;, 11&bgr;-PGF2&agr; in a patient.
    Type: Application
    Filed: December 16, 2002
    Publication date: October 2, 2003
    Applicant: METABOLEX, INC.
    Inventors: Steve Waters, Shonna Moodie, Brian Lavan, Thomas A. Gustafson